LDL-lowering potency varies between agents. Cerivastatin is the most potent (withdrawn from the market in August 2001 due to risk of serious rhabdomyolysis), followed by (in order of decreasing potency) rosuvastatin, atorvastatin, simvastatin, lovastatin, pravastatin, and fluvastatin. The relative potency of pitavastatin has not yet been fully established, but preliminary studies indicate a potency similar to rosuvastatin.
ldl-lowering potency varies between agents cerivastatin is the most potent (withdrawn from the market in august 2001 due to risk of serious rhabdomyolysis) followed by (in order of decreasing potency) rosuvastatin atorvastatin simvastatin lovastatin pravastatin and fluvastatin the relative potency of pitavastatin has not yet been fully established but preliminary studies indicate a potency similar to rosuvastatin